The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 24, 2023

Filed:

May. 04, 2021
Applicant:

Aqsens Health Oy, Turku, FI;

Inventors:

Janne Kulpakko, Turku, FI;

Jouko Vepsäläinen, Kuopio, FI;

Susanna Paavilainen, Numminen, FI;

Assignee:

Aqsens Health Oy, Turku, FI;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
G01N 21/64 (2006.01); G01N 33/84 (2006.01); G01N 21/78 (2006.01); A61B 5/00 (2006.01);
U.S. Cl.
CPC ...
G01N 21/6428 (2013.01); A61B 5/4381 (2013.01); G01N 21/78 (2013.01); G01N 33/84 (2013.01); G01N 2021/6439 (2013.01); G01N 2800/7028 (2013.01);
Abstract

The present disclosure relates to a method for detecting a prostate cancer related biomarker, including contacting the diluted sample with a modulating agent selected from a group consisting of sodium; 3-hydroxy-4-[(2-hydroxynaphthalen-1-yl)diazenyl]naphthalene-1-sulfonate, sodium; 3-hydroxy-4-[(1-hydroxynaphthalen-2-yl)diazenyl]-7-nitronaphthalene-1-sulfonate, triisopropylsilane, and iron(III) chloride, and a luminescent label to obtain a measurement sample. Then, the measurement sample is incubated for a period of time and excited thereafter. Time-resolved luminescence signal of the label in the measurement sample is measured, leading to an increased likelihood of prostate cancer of the human subject if the luminescence signal is at least 50% higher than for a control sample from a human subject without prostate cancer.


Find Patent Forward Citations

Quick Actions:

Kulpakko, Janne. (2023). Method for detecting a prostate cancer biomarker (U.S. Patent No. 11796470). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11796470

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…